| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C417207 |
2,2',4,6,6'-pentachlorobiphenyl |
2,2',4,6,6'-pentachlorobiphenyl results in increased activity of REL protein | increases activity | 16611624
|
| C018855 |
2-tert-butylhydroquinone |
2-tert-butylhydroquinone results in increased expression of REL mRNA | increases expression | 16014739
|
| C108123 |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of REL protein] | decreases reaction|increases activity | 15772366
|
| C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of REL mRNA | decreases expression | 12419474
|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of REL mRNA | affects expression | 17562736
|
| C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of REL protein | decreases expression | 18349030
|
| D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of REL mRNA | decreases expression | 12419474
|
| D002258 |
Carbonyl Cyanide m-Chlorophenyl Hydrazone |
Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of REL protein | increases expression | 15978749
|
| C503589 |
cis-9, trans-11-conjugated linoleic acid |
cis-9, trans-11-conjugated linoleic acid affects the activity of REL protein | affects activity | 17327424
|
| C007262 |
deoxynivalenol |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of REL protein] | decreases reaction|increases activity | 15772366
|
| C007262 |
deoxynivalenol |
deoxynivalenol affects the localization of REL protein | affects localization | 12604842
|
| C007262 |
deoxynivalenol |
deoxynivalenol results in decreased activity of [REL protein binds to NFKB1 protein] | affects binding|decreases activity | 8887449
|
| C007262 |
deoxynivalenol |
deoxynivalenol results in increased activity of REL protein | increases activity | 15772366
|
| D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of REL mRNA | decreases expression | 18042831
|
| D015127 |
9,10-Dimethyl-1,2-benzanthracene |
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]] | affects binding|decreases reaction|increases reaction | 14678569
|
| D004317 |
Doxorubicin |
Doxorubicin affects the localization of REL protein | affects localization | 15870702
|
| D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of REL mRNA | decreases expression | 16404146
|
| D004317 |
Doxorubicin |
REL protein affects the susceptibility to Doxorubicin | affects response to substance | 17890907
|
| D005033 |
Ethylmaleimide |
Ethylmaleimide results in decreased phosphorylation of REL protein | decreases phosphorylation | 11085954
|
| D005620 |
Freund's Adjuvant |
[Urethane co-treated with Freund's Adjuvant] results in increased expression of REL mRNA | affects cotreatment|increases expression | 12400877
|
| C007789 |
fucoidan |
fucoidan results in decreased activity of REL protein | decreases activity | 16201850
|
| D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased localization of REL protein | decreases localization | 16249388
|
| D006861 |
Hydrogen Peroxide |
Trifluoperazine inhibits the reaction [Hydrogen Peroxide results in decreased localization of REL protein] | decreases localization|decreases reaction | 16249388
|
| C050016 |
lipoarabinomannan |
lipoarabinomannan results in decreased localization of and results in decreased activity of REL protein | decreases activity|decreases localization | 16263713
|
| D008070 |
Lipopolysaccharides |
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]] | affects binding|decreases reaction|increases reaction | 14678569
|
| D008070 |
Lipopolysaccharides |
Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter] | affects binding|increases reaction | 14678569
|
| D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased activity of and results in increased localization of REL protein | increases activity|increases localization | 19159680
|
| D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of REL mRNA | increases expression | 20423518 12057914
|
| D008070 |
Lipopolysaccharides |
Lithium promotes the reaction [Lipopolysaccharides results in increased localization of REL protein] | increases localization|increases reaction | 19159680
|
| D008070 |
Lipopolysaccharides |
phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of REL mRNA] | decreases reaction|increases expression | 20423518
|
| D008094 |
Lithium |
Lithium promotes the reaction [Lipopolysaccharides results in increased localization of REL protein] | increases localization|increases reaction | 19159680
|
| C029938 |
nickel sulfate |
nickel sulfate results in decreased expression of REL mRNA | decreases expression | 16780908
|
| C029938 |
nickel sulfate |
nickel sulfate results in increased expression of REL mRNA | increases expression | 16780908
|
| D009761 |
Nystatin |
Nystatin results in increased activity of REL protein | increases activity | 16374455
|
| C041786 |
palm oil |
palm oil results in decreased expression of REL mRNA | decreases expression | 18042831
|
| C058305 |
phenethyl isothiocyanate |
phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of REL mRNA] | decreases reaction|increases expression | 20423518
|
| C008922 |
piperine |
piperine results in decreased localization of REL protein | decreases localization | 15531295
|
| C526689 |
punarnavine |
punarnavine results in decreased localization of REL protein | decreases localization | 20192578
|
| D019438 |
Ritonavir |
Ritonavir results in decreased activity of REL protein | decreases activity | 16174765
|
| C018145 |
scoparone |
scoparone inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of REL protein] | affects localization|decreases reaction | 16376386
|
| C017947 |
sodium arsenite |
sodium arsenite results in increased expression of REL mRNA | increases expression | 16014739
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of REL mRNA | increases expression | 12377990
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [TNF protein results in increased localization of REL protein] | decreases reaction|increases localization | 12181450
|
| D013755 |
Tetradecanoylphorbol Acetate |
scoparone inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of REL protein] | affects localization|decreases reaction | 16376386
|
| D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate affects the localization of REL protein | affects localization | 16376386
|
| D014212 |
Tretinoin |
Tretinoin results in increased expression of REL mRNA | increases expression | 16140955
|
| D014268 |
Trifluoperazine |
Trifluoperazine inhibits the reaction [Hydrogen Peroxide results in decreased localization of REL protein] | decreases localization|decreases reaction | 16249388
|
| D014415 |
Tunicamycin |
Tunicamycin results in increased expression of REL mRNA | increases expression | 17127020
|
| D014520 |
Urethane |
[Urethane co-treated with Freund's Adjuvant] results in increased expression of REL mRNA | affects cotreatment|increases expression | 12400877
|
| D014520 |
Urethane |
Urethane results in increased expression of REL mRNA | increases expression | 12400877
|
| D014635 |
Valproic Acid |
Valproic Acid results in increased expression of REL mRNA | increases expression | 19101580
|
| D015215 |
Zidovudine |
REL protein results in decreased susceptibility to [Zidovudine co-treated with IFNA1 protein] | affects cotreatment|decreases response to substance | 17138822
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.05 | 14514962 11752688 15322242 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.05 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.59 | 19490988 |
| MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.45 | 9612607 |
| MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.32 | 11850527 18653653 |
| MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
8.32 | 19131640 16100012 11954676 12718980 |
| MESH:D000230 |
Adenocarcinoma |
|
9,10-Dimethyl-1,2-benzanthracene |
9.44 | 12844480 10697514 |
| MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.44 | 11798837 19825857 |
| MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
9.44 | 17418594 |
| MESH:D000230 |
Adenocarcinoma |
|
Urethane |
9.44 | 18316556 |
| MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
5.32 | 15814487 |
| MESH:D000236 |
Adenoma |
|
9,10-Dimethyl-1,2-benzanthracene |
7.00 | 11376689 |
| MESH:D000236 |
Adenoma |
|
Urethane |
7.00 | 11497255 16926031 10822126 10530776 6695378 17195641 17093202 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.00 | 16835633 |
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.31 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.51 | 17306315 16712894 |
| MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.18 | 21441931 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.32 | 15955085 |
| MESH:D000544 |
Alzheimer Disease |
|
Lithium |
3.38 | 19621015 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.84 | 17688650 |
| MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.86 | 10965797 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.62 | 11748828 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.46 | 10982225 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.27 | 17497229 |
| MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.52 | 15238619 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.84 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
marker/mechanism |
|
| 19503088 20453842 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.17 | 16292516 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
2.22 | 16456186 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 18775368 18316065 17157402 18940202 16609825 20603192 18177632 18558336 17688650 15238991 19232924 18396377 17507914 18985861 19460635 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.04 | 16935849 |
| MESH:D001714 |
Bipolar Disorder |
|
Lithium |
6.95 | 20338123 19153942 20046352 17594078 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
6.95 | 20046352 17594078 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
13.37 | 16206674 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.37 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.37 | 16206674 16197459 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.40 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.20 | 15746008 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.20 | 8888407 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.31 | 14601052 |
| MESH:D001862 |
Bone Resorption |
|
Freund's Adjuvant |
4.79 | 16769263 |
| MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.48 | 17150277 |
| MESH:D001943 |
Breast Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
2.23 | 15565634 20435547 17127718 18840765 16153821 |
| MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.23 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.23 | 17369602 16096432 15993339 15136595 16115903 18695136 15567936 18628466 16826403 18382427 17426702 15939500 15692762 16935488 18234424 16264153 11325840 15634643 19526202 16595493 15994142 17983394 15668708 16322301 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.23 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.23 | 16873071 16443354 16166294 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.21 | 16813970 |
| MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.98 | 11589617 |
| MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.42 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.50 | 16835633 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.77 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.11 | 3084413 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
8.11 | 14691202 15553829 16217749 11135700 15073043 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.11 | 16023760 16234567 17876044 18059187 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.11 | 16507464 15276417 17306315 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.11 | 1917145 |
| MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.49 | 19014326 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
2.98 | 1485588 16201981 |
| MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.79 | 12490120 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
9,10-Dimethyl-1,2-benzanthracene |
13.06 | 11376689 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
13.06 | 6189445 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
13.06 | 18572023 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
13.06 | 18922899 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
13.06 | 16096774 16051514 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.15 | 18850075 16120746 18670907 |
| MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.28 | 16109756 17928571 17924179 17007740 17351982 16455267 18627295 16952015 17382496 16278810 17308081 17519947 16651473 16364871 15505089 15792986 15476868 16612575 16269455 15811867 17974986 16242529 16731534 17131338 17329180 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.81 | 17334414 16243910 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.25 | 16936243 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
6.47 | 10977129 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
6.47 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
2.73 | 20056578 19524636 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.21 | 16129372 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.56 | 20734317 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.77 | 16461808 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
8.94 | 15668235 16354765 12621046 15340226 8697196 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
8.94 | 9407595 |
| MESH:D002972 |
Cleft Palate |
|
Urethane |
8.94 | 12810352 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
3.33 | 17035595 |
| MESH:D003093 |
Colitis, Ulcerative |
|
phenethyl isothiocyanate |
3.51 | 20423518 |
| MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.50 | 20501625 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.50 | 18259882 18802399 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.74 | 14669216 17141729 |
| MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.82 | 12609071 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
4.99 | 10525206 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.99 | 20055451 10048152 15322242 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
4.99 | 17551590 8800419 10589399 9224671 16925845 14991402 9664655 9211117 9142499 9125849 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
4.99 | 8888407 17688650 16575769 |
| MESH:D007644 |
Darier Disease |
|
Lithium |
5.53 | 20338123 |
| MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.74 | 15213294 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
3.32 | 11298694 16780908 16823706 |
| MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.37 | 19244398 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.57 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
10.70 | 11739529 12594235 11287661 16227642 19739265 19420014 11743745 19923254 16177239 14986274 12705907 11834606 16781746 16081117 17906064 16393943 19416960 16485898 18071297 2444490 18713872 11529661 11461765 16109766 11421492 19164858 17522070 12392966 10915739 10774834 15968718 17562736 19085960 19370779 14725611 12958197 12153990 15619225 10663392 14550746 12540782 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
10.70 | 17416283 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Ritonavir |
10.70 | 14986274 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
10.70 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
10.70 | 1733752 19641884 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.71 | 19426721 |
| MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
12.16 | 18602426 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
12.16 | 11462148 |
| MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
12.16 | 15040536 |
| MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.18 | 18367378 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.70 | 1851702 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.85 | 12711302 11000095 |
| MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
5.85 | 16716910 7812673 9599246 11698051 8273558 8113982 15177302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.65 | 18230668 15322242 16714409 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.65 | 18230668 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
6.75 | 17359293 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.75 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.69 | 9294722 10568697 |
| MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.77 | 18037988 |
| MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.02 | 15328337 15821434 17637181 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.78 | 3659116 17275665 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.53 | 16628512 3922381 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.74 | 18234410 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.27 | 6426943 7562514 6254150 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.92 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.68 | 3659116 |
| MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.21 | 12903497 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.90 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.90 | 9664655 16938888 |
| MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
16.05 | 15073043 |
| MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
16.05 | 17967931 18296743 19551842 19004024 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
16.05 | 14986274 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Zidovudine |
16.05 | 18299183 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.08 | 11858732 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.50 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.77 | 18558336 8888407 |
| MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.69 | 11852909 9205823 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.21 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Dietary Fats |
12.62 | 18296743 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.62 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
12.62 | 17994277 |
| MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.90 | 16904648 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.29 | 16983495 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.30 | 16452187 |
| MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
6.41 | 17150277 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.41 | 17312396 |
| MESH:D005922 |
Glomerulonephritis, IGA |
|
deoxynivalenol |
4.71 | 15173396 16524712 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.21 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
6.99 | 15692506 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
6.99 | 16096774 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.77 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
10.10 | 19638421 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.10 | 10048152 11294989 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.10 | 9664655 14991402 |
| MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.22 | 16879835 12587719 16244372 16244371 18006777 18674790 16495754 14766674 17875725 17888722 16144979 16330681 16707910 |
| MESH:D006331 |
Heart Diseases |
|
Urethane |
7.22 | 16046796 |
| MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.11 | 17481944 |
| MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.56 | 15692506 |
| MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.36 | 12579204 |
| MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.05 | 16366002 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.00 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.53 | 16120746 12621046 15340226 |
| MESH:D015658 |
HIV Infections |
|
Ritonavir |
6.68 | 17378895 11363243 15388451 11141242 |
| MESH:D015658 |
HIV Infections |
|
Zidovudine |
6.68 | 11141242 20032539 11363243 11698656 17358032 |
| MESH:D006689 |
Hodgkin Disease |
marker/mechanism |
|
| 21037568 |
| MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
6.43 | 17606976 15147373 18501091 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.43 | 12676792 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.48 | 17688650 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.66 | 8697196 18606429 15340226 16959395 16354765 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
11.47 | 16870215 |
| MESH:D006930 |
Hyperalgesia |
|
Freund's Adjuvant |
11.47 | 16769263 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
11.47 | 16870215 |
| MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.26 | 21332399 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.20 | 16778211 |
| MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.27 | 21332399 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.76 | 18850075 18670907 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.74 | 12646999 15346721 |
| MESH:D007249 |
Inflammation |
|
Dietary Fats |
13.72 | 20412841 |
| MESH:D007249 |
Inflammation |
|
Freund's Adjuvant |
13.72 | 16793879 |
| MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
13.72 | 17237260 9205823 12878042 17963957 17255318 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
13.72 | 12878042 12200463 |
| MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
13.72 | 11698051 7812673 15177302 8273558 7562506 |
| MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
2.86 | 18457598 11836018 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.40 | 17994277 |
| MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.28 | 17255318 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.80 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.80 | 15992940 17551590 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
8.80 | 12587719 15629191 |
| MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
8.80 | 16775033 15369732 15699352 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
8.80 | 20008137 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.99 | 16707910 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
8.99 | 16518626 |
| MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
3.48 | 12579204 |
| MESH:D007938 |
Leukemia |
|
arsenic trioxide |
5.69 | 15070760 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
5.69 | 17143497 |
| MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.77 | 16085563 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
14.53 | 17077332 12560223 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Ritonavir |
14.53 | 16174765 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
14.53 | 20370541 |
| MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.93 | 16972261 |
| MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.15 | 14633726 |
| MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
8.34 | 19077051 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.34 | 16482212 19285840 16932348 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.64 | 19850784 17050201 16968895 16467208 20471514 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.64 | 19850784 16294345 17596541 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
5.64 | 17596541 16294345 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
6.80 | 12712474 16112521 17107899 16330433 19075265 16331271 12679006 15748426 16823087 16966277 17869043 12018890 15622746 11161223 17649720 17217047 19225113 11468182 19642359 15336539 17712046 9834237 15213294 19035177 16891316 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
6.80 | 17368321 19029980 16766008 16891316 16140955 19642359 15748426 19225113 16331271 19035177 17217047 17107899 17506722 17294898 12679006 16823087 9834237 16935935 17339181 16788101 19075265 17301526 17712046 17649720 17361223 |
| MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.99 | 16882451 |
| MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.32 | 15821434 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.04 | 9224671 |
| MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.67 | 18296743 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
cis-9, trans-11-conjugated linoleic acid |
6.19 | 17869086 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
6.19 | 16439617 16595196 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
6.19 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.19 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.19 | 16248980 18397230 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.54 | 16610002 16611625 19014921 12969438 19784758 11587558 19460945 12587719 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.91 | 17185352 16871587 |
| MESH:D008113 |
Liver Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
12.63 | 9643874 |
| MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
12.63 | 14682389 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
12.63 | 16712894 15276417 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
12.63 | 16984957 |
| MESH:D008113 |
Liver Neoplasms |
|
Urethane |
12.63 | 17559639 17093202 16391232 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
9,10-Dimethyl-1,2-benzanthracene |
12.23 | 1399818 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
12.23 | 20377131 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
12.23 | 17085340 16842330 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.23 | 12151625 |
| MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.06 | 15213294 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.92 | 19095001 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.87 | 17228818 |
| MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.64 | 21114838 |
| MESH:D008175 |
Lung Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
12.02 | 11376689 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
12.02 | 19825857 11798837 |
| MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
12.02 | 6189445 17418594 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
12.02 | 16712894 17306315 15276417 17077188 19931552 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
12.02 | 19555203 11884234 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
12.02 | 11807781 |
| MESH:D008175 |
Lung Neoplasms |
|
Urethane |
12.02 | 12765245 7750092 16926031 16007126 12466968 15902970 14587096 16391232 11807781 11246140 11552296 17093202 17255336 17195641 15136453 12117781 10822126 11062179 11992545 16337739 11074608 10779650 16289808 16788158 12957351 11497255 11544531 10530776 11323394 15166089 10997738 16204055 11307925 6695378 11893704 |
| MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
12.02 | 18800350 |
| MESH:D008223 |
Lymphoma |
|
9,10-Dimethyl-1,2-benzanthracene |
7.32 | 11376689 |
| MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.32 | 16098063 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.48 | 17654614 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.19 | 15621674 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
9,10-Dimethyl-1,2-benzanthracene |
8.90 | 16082771 18840765 1500032 16153821 8985016 12844480 11807958 10697514 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
8.90 | 15458769 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
8.90 | 8985016 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.63 | 17453147 |
| MESH:D008545 |
Melanoma |
|
Doxorubicin |
4.70 | 16827129 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.70 | 16487513 19082730 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
4.70 | 16752155 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.20 | 19513568 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.05 | 16940565 |
| MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.90 | 17638057 |
| MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
5.45 | 17358032 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.92 | 18765137 18803445 |
| MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.16 | 15792986 |
| MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.41 | 17415656 |
| MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
2.84 | 14977855 15949261 19549372 19417148 11468182 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.69 | 8888407 |
| MESH:D009164 |
Mycobacterium Infections |
|
Ritonavir |
5.39 | 21442799 |
| MESH:D009181 |
Mycoses |
|
Nystatin |
6.38 | 16374455 |
| MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.28 | 18349030 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
11.02 | 16105982 16882451 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
11.02 | 17596541 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
11.02 | 17596541 |
| MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.81 | 19429709 15857846 |
| MESH:D009203 |
Myocardial Infarction |
|
Lithium |
5.81 | 16288908 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.72 | 12213967 |
| MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.60 | 16624393 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.08 | 18259882 |
| MESH:D009362 |
Neoplasm Metastasis |
|
punarnavine |
6.08 | 19171408 |
| MESH:D009369 |
Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
10.39 | 11544531 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
10.39 | 11559025 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
10.39 | 16946489 16594593 |
| MESH:D009369 |
Neoplasms |
|
Urethane |
10.39 | 15625555 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.24 | 20056578 |
| MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
8.24 | 15582191 |
| MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.40 | 16899518 16636307 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.68 | 16889571 15640375 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.31 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
8.31 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
15.27 | 10525206 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
15.27 | 12854658 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
15.27 | 9142499 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
15.27 | 8888407 16359493 |
| MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.06 | 15555623 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.56 | 18514411 |
| MESH:D009503 |
Neutropenia |
|
Ritonavir |
5.02 | 17378895 |
| MESH:D009765 |
Obesity |
|
Dietary Fats |
2.19 | 16723640 21332399 20132043 19632207 18674790 18457598 17217161 11836018 20518802 |
| MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.81 | 15930896 |
| MESH:D010051 |
Ovarian Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
13.62 | 16891317 |
| MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
13.62 | 16624393 19769630 12452020 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
13.62 | 15276417 17306315 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
13.62 | 16936753 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
13.62 | 16391232 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
5.58 | 16870215 |
| MESH:D010146 |
Pain |
|
Tretinoin |
5.58 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
7.85 | 15580305 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
7.85 | 15976015 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
7.85 | 15976015 |
| MESH:D010212 |
Papilloma |
|
9,10-Dimethyl-1,2-benzanthracene |
13.72 | 16517061 15173996 17234724 |
| MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
13.72 | 12065085 |
| MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
13.72 | 18922899 8330346 18404319 12065085 |
| MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.81 | 19927285 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.86 | 12520081 |
| MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.11 | 11550810 |
| MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.77 | 17983394 |
| MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
5.04 | 16391232 |
| MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.77 | 17638057 |
| MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.17 | 12224865 11605937 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.20 | 18163543 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.20 | 11399792 11118676 11896295 11222880 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
8.20 | 20603192 |
| MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.76 | 19131511 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.76 | 16868541 16888761 16729912 15749863 15897917 18437689 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.76 | 16039940 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.26 | 16636307 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.15 | 12752131 11422049 |
| MESH:D011565 |
Psoriasis |
marker/mechanism |
|
| 20953190 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.41 | 16723453 |
| MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.85 | 17922066 |
| MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.48 | 10835634 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.47 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.70 | 16283617 16116481 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
9.70 | 19155313 |
| MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.66 | 15625365 18313854 17710206 15675481 17203757 16767912 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
9.08 | 16646077 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
9.08 | 16326096 14601052 |
| MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.41 | 17846226 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.02 | 15737665 19110320 |
| MESH:D012640 |
Seizures |
|
Lithium |
5.62 | 19660546 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
5.62 | 16876388 3137016 17978042 14763951 11738929 11044598 15475178 1511512 |
| MESH:D012878 |
Skin Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
33.39 | 15173996 8985016 16517061 11376689 |
| MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
33.39 | 15692506 |
| MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
33.39 | 12065085 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
33.39 | 19524636 18572023 |
| MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
33.39 | 8532709 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
33.39 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
33.39 | 18404319 8985016 8330346 12065085 11807781 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
33.39 | 16467112 |
| MESH:D012878 |
Skin Neoplasms |
|
Urethane |
33.39 | 11807781 |
| MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.19 | 15625365 16767912 17203757 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.57 | 12854658 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.57 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Lithium |
11.37 | 19430551 19951488 19570321 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
11.37 | 12833885 |
| MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.23 | 17007042 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.23 | 17261132 |
| MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
3.23 | 17696246 |
| MESH:D013276 |
Stomach Ulcer |
|
fucoidan |
4.77 | 15138204 18209962 |
| MESH:D013733 |
Testicular Diseases |
|
phenethyl isothiocyanate |
4.56 | 15864552 |
| MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.84 | 15821434 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.51 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
14.84 | 16940797 |
| MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
14.84 | 19014326 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
14.84 | 17909728 16010429 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
14.84 | 16026305 17045167 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.46 | 16051514 |
| MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.58 | 15213294 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.84 | 17262798 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.99 | 16040207 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.14 | 3119515 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
7.47 | 12845720 20435036 12973940 11780464 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
7.47 | 17653716 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
7.47 | 17306315 11723127 16712894 16452187 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.63 | 10982225 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.32 | 11813266 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.32 | 16129372 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.22 | 16752155 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
4.39 | 12579204 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.04 | 17056641 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.21 | 12125929 |
| MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
5.52 | 10620525 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.85 | 17334414 17638931 17678736 16364871 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.69 | 16761959 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.86 | 15886252 |
| MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.42 | 16723640 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.65 | 16287080 |